Ventas stock performance snapshot after recent trading moves
Ventas (VTR) shares last closed at US$91.17, with the stock down about 1% over the past day and about 2% over the past week, while still showing stronger multi year total returns.
For context, Ventas has given up some short term share price momentum, with a 30 day share price return of about 3% in decline and a 90 day share price return of about 14% in gain. Longer term total shareholder returns over three and five years remain strong, which hints that recent moves may reflect shorter term shifts in sentiment rather than a complete change in the company’s risk or growth profile.
Scan beyond Ventas and spot other real estate and income focused businesses with resilient returns using our hand picked 74 resilient stocks with low risk scores in seconds.
Ventas has pulled back in the short term while sitting below both analyst targets and one measure of intrinsic value. Is that gap a signal of underappreciated upside, or a fair discount to the current outlook on the business?
Most Popular Narrative: 8% Undervalued
The most followed narrative on Ventas puts fair value at about $99.05 a share versus the last close at $91.17. That gap reflects a detailed view on how its real estate portfolio and earnings power could evolve in the coming years.
Ventas is positioned to benefit from a rapidly growing aging population driving sustained demand for senior housing and healthcare facilities, combined with historically low new construction, supporting multi-year occupancy gains and net operating income (NOI) growth as occupancy rates rise from the low 80% toward the 90%+ level. This is likely to drive substantial operating leverage and margin expansion.
There is a full set of moving parts behind that fair value. Revenue growth that compounds over several years. Profit margins that step up from today’s levels. And an earnings multiple that assumes investors are willing to pay a premium for that profile. Curious which of those levers does most of the heavy lifting in this narrative.
Result: Fair Value of $99.05 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, keep in mind that weaker operator execution in senior housing or softer returns from acquisition-led growth could quickly challenge this upbeat Ventas narrative.
Find out about the key risks to this Ventas narrative.
Another view on Ventas valuation
The community narrative and analyst target both point to Ventas trading below an implied fair value, but the picture changes when looking at the P/S ratio. Ventas trades on a P/S of 7.3x versus a fair ratio of 6x, and an industry average of 5.4x, which suggests investors are already paying a premium. The key question is whether that premium still leaves enough room for error in your own assumptions.
To see how this price based view lines up with the rest of the numbers, including growth, margins and peers, take a closer look at the See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With Ventas showing both potential rewards and clear risk flags, it may be useful to move promptly and review the full picture for yourself. A good place to start is by weighing the 3 key rewards and 3 important warning signs.
Looking for more investment ideas beyond Ventas?
If Ventas has you thinking about how to strengthen your portfolio, do not stop here. The next move might come from a stock you have not checked yet.
- Target reliable cash flows by reviewing companies highlighted in the 12 dividend fortresses that focus on income strength and payout resilience.
- Spot potential bargains early by scanning the 19 high quality undiscovered gems that combine quality fundamentals with lower market attention.
- Strengthen your downside protection by filtering for companies with robust finances through the list of solid balance sheet and fundamentals (52 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com